The efficacy and safety of lenvatinib in patients with intermediate-stage hepatocellular carcinoma: A nationwide multicenter study in Japan.

Kaoru Tsuchiya,Masayuki Kurosaki,Azusa Sakamoto,Hiroyuki Marusawa,Chikara Ogawa,Masahiko Kondo,Kouji Joko,Keiji Tsuji,Hiroyuki Kimura,Shuichi Wada,Haruhiko Kobashi,Yasushi Uchida,Koichiro Furuta,Takehiro Akahane,Atsunori Kusakabe,Hideo Yoshida,Tomomichi Matsushita,Takehiko Abe,Tetsuro Sohda,Namiki Izumi

The efficacy and safety of lenvatinib in patients with intermediate-stage hepatocellular carcinoma: A nationwide multicenter study in Japan.

2020

548Background: Lenvatinib (LEN) has been used in patients with unresectable hepatocellular carcinoma (u-HCC) since Mar 2018 in Japan. We conducted a nationwide multicenter study and especially focu...

Keywords:

Lenvatinib
Hepatocellular carcinoma
Internal medicine
Medicine
Oncology
multicenter study
Pathology
in patient
intermediate stage

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations